In Brief: Cosmetic Specialty Labs warning letter
This article was originally published in The Rose Sheet
Executive Summary
Cosmetic Specialty Labs warning letter: Cites the Lawton, Okla.-based skin care manufacturer for violations of Good Manufacturing Practices regs. In a June 26 letter, FDA states that Cosmetic Specialty Labs has failed to conduct laboratory analysis of identity and strength of each product, document microbial analysis and conduct stability testing. The agency also notes the company lacks written procedures for a number of production steps...